"ThermalTherapeutic Systems is positioned to provide medical professionals with the most advanced technology in the field of hyperthermic perfusion," said Mr. Smith. "We have an FDA-cleared device that is being used by leading physicians in the treatment of critically ill cancer patients. Our product, VERATHERM™, fills an unmet medical need in North America , Europe and Asia . We continue to invest in providing our customers the tools and service support they need which enable them to treat patients with the best available therapeutic regimen on a cost efficient basis."
Peter M. DeComo , Chairman of the Board said, "ThermalTherapeutic Systems is a growth stage company launching a 'disruptive' new product into the marketplace. Gardiner's impressive track record of building successful companies and guiding them through growth and product launch makes him a tremendous addition to the TTS team at a critical time in our development. I am confident ThermalTherapeutic Systems is poised for continued growth to become the market leader."
Mike Gausling , Managing Partner of Originate Ventures said, "We are grateful to Raymond for his strong leadership to guide us from inception through the FDA clearance for VERATHERM™. As we shift our focus to being a commercial enterprise, we are delighted that Gardiner Smith has agreed to join the company to lead our sales and marketing efforts to establish VERATHERM™ as the new standard of care in the field of hyperthermic perfusion."
About ThermalTherapeutic Systems
ThermalTherapeutic Systems, Inc. was founded in 2006 by a team of experts in the field of hyperthermic perfusion, medical device manufacturing, molecular diagnostics and technology commercialization. ThermalTherapeutic Systems is a product development company and the VERATHERM™ Portable Hyperthermic Perfusion System the company's first product offering. www.thermaltherapeutics.com
